证券代码：605001 证券简称：威奥股份 公告编号：2025-029 青岛威奥轨道股份有限公司 关于 2025 年半年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2025 年 8 月 26 日，青岛威奥轨道股份有限公司（以下简称"公司"）召开 第三届董事会第二十八次会议和第三届监事会第十六次会议，审议通过了《关于 计提资产减值准备的议案》，根据《企业会计准则》和公司会计政策的相关规定， 2025 年 6 月 30 日公司计提各类资产减值准备共计 13,036,333.14 元。具体如下： 一、 本次计提资产减值准备情况概述 2、合同资产减值准备 根据《企业会计准则》和公司会计政策的相关规定，为客观、公允地反映公 司 2025 年 6 月 30 日财务状况及经营成果，公司及下属子公司对截至 2025 年 6 月 30 日的公司资产进行了充分的评估和分析，本着谨慎性原则，对相关资产进 行了减值测试并计提了相应的资产减值准备。2025 年 6 月 30 日公司各类资产减 值准备共计提 13,03 ...

证券代码：605001 证券简称：威奥股份 公告编号：2025-027 青岛威奥轨道股份有限公司 关于2025年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据中国证券监督管理委员会（以下简称"中国证监会"）《上市公司监管 指引第 2 号-上市公司募集资金管理和使用的监管要求》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》《青岛威奥轨道股份有限公司募集资金管 理办法》（以下简称"《募集资金管理办法》"）的有关规定，现将青岛威奥轨道 股份有限公司（以下简称"公司"）截至 2025 年 6 月 30 日的募集资金存放与实 际使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准青岛威奥轨道股份有限公司首次公开 发行股票的批复》（证监许可〔2020〕636 号）核准，公司首次公开发行人民币 普通股（A 股）7,556.00 万股，发行价格 16.14 元/股，募集资金总额为人民币 1,219,538,40 ...

Group 1 - The high-pressure oxygen chamber concept sector experienced a decline of 0.76%, ranking among the top declines in concept sectors as of the market close on August 22 [1] - Within the sector, major declines were observed in companies such as Samsung Medical, Aoyang Health, and Dahu Co., with notable increases in Hangyang Co., Yinkang Life, and International Medicine, which rose by 0.97%, 0.86%, and 0.37% respectively [1] Group 2 - The high-pressure oxygen chamber concept sector saw a net outflow of 260 million yuan in principal funds today, with six stocks experiencing net outflows [2] - The stock with the highest net outflow was Tiedao Heavy Industry, which had a net outflow of 143 million yuan, followed by Innovative Medical, Samsung Medical, and Aoyang Health with net outflows of 60.83 million yuan, 43.65 million yuan, and 13.12 million yuan respectively [2] - Conversely, the stocks with the highest net inflows included International Medicine, Jinling Pharmaceutical, and Yinkang Life, with net inflows of 3.35 million yuan, 3.27 million yuan, and 3.20 million yuan respectively [2]

近日，宿青燕女士与上海张江科技小额贷款股份有限公司办理完 毕股份解除质押业务，具体情况如下： 股东名称 宿青燕 本次解除质押股份 23,900,000 股 占其所持股份比例 24.23% 占公司总股本比例 6.08% 解除质押时间 2025 年 8 月 20 日 持股数量 98,619,925 股 持股比例 25.10% 剩余被质押股份数量 65,500,000 股 剩余被质押股份数量占其所持股份比例 66.42% 剩余被质押股份数量占公司总股本比例 16.67% 宿青燕女士本次解除质押的股份，将根据其未来资金需求情况确 定是否进行质押，并根据相关要求及时履行信息披露义务。 证券代码：605001 证券简称：威奥股份 公告编号：2025-024 青岛威奥轨道股份有限公司 关于控股股东部分股份解除质押及质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: ? 青岛威奥轨道股份有限公司（以下简称"公司"）股东宿青燕女 士持有公司股份 98,619,925 股，占公司总股本的 25.10%。本次办理 部分股份 ...

2024年1至12月份，威奥股份的营业收入构成为：轨道交通设备及其延伸产业占比86.91%，新能源汽车 配套行业占比7.89%，智能消费设备制造行业占比3.79%，其他业务占比1.42%。 威奥股份（SH 605001，收盘价：7.85元）8月21日晚间发布公告称，青岛威奥轨道股份有限公司股东宿 青燕女士持有公司股份约9862万股，占公司总股本的25.1%。本次办理部分股份解除质押业务及质押业 务后，宿青燕女士持有公司股份累计质押数量（含本次）为6550万股，占其持有公司股份总数的 66.42%。本次解除质押业务及质押业务完成后，股东宿青燕女士及其一致行动人孙汉本先生、孙继龙 先生、青岛威奥股权投资有限公司累计质押股份数量为6900万股，占其持股总数的44.72%，占公司总 股本17.56%。 （文章来源：每日经济新闻） ...

青岛威奥轨道股份有限公司（以下简称"公司"）股东宿青燕女 士持有公司股份 98,619,925 股，占公司总股本的 25.10%。本次办理 部分股份解除质押业务及质押业务后，宿青燕女士持有公司股份累计 质押数量（含本次）为 65,500,000 股，占其持有公司股份总数的 66.42%。 证券代码：605001 证券简称：威奥股份 公告编号：2025-024 青岛威奥轨道股份有限公司 关于控股股东部分股份解除质押及质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: 本次解除质押业务及质押业务完成后，股东宿青燕女士及其一 致行动人孙汉本先生、孙继龙先生、青岛威奥股权投资有限公司累计 质押股份数量为 69,000,000 股，占其持股总数的 44.72%，占公司总 股本 17.56%。 一、本次股份解除质押情况 近日，宿青燕女士与上海张江科技小额贷款股份有限公司办理完 毕股份解除质押业务，具体情况如下： | | | 1 | 本次解除质押股份 | 23,900,000 股 | | --- | --- | | ...

Group 1 - The high-pressure oxygen chamber concept declined by 0.68%, ranking among the top declines in concept sectors as of the market close on August 20 [1] - Within the high-pressure oxygen chamber sector, companies such as Innovate Medical, Yinkang Life, and Aoyang Health experienced significant declines, while Iron Construction Heavy Industry, Samsung Medical, and Dahu Co. saw increases of 4.29%, 1.08%, and 0.89% respectively [1] - The high-pressure oxygen chamber sector experienced a net outflow of 444 million yuan in main funds, with Innovate Medical leading the outflow at 537 million yuan [2] Group 2 - The top gainers in the market included the Tonghuashun Fruit Index at 3.70%, AI mobile phones at 2.77%, and MCU chips at 2.60%, while the high-pressure oxygen chamber concept was among the top decliners [2] - The main funds saw significant outflows from several stocks in the high-pressure oxygen chamber sector, with Innovate Medical, Aoyang Health, and Dahu Co. being the most affected [2] - Conversely, Iron Construction Heavy Industry, Samsung Medical, and Jinling Pharmaceutical attracted net inflows of main funds, indicating a shift in investor interest [2]

Market Overview - The rail transit equipment sector experienced a decline of 2.86% on August 14, with Yonggui Electric leading the drop [1] - The Shanghai Composite Index closed at 3666.44, down 0.46%, while the Shenzhen Component Index closed at 11451.43, down 0.87% [1] Stock Performance - Yonghui Electric (300351) closed at 18.52, down 7.86% with a trading volume of 510,500 shares and a transaction value of 966 million [1] - Quantang Heavy Industry (301048) closed at 12.97, down 7.75% with a trading volume of 404,100 shares and a transaction value of 536 million [1] - Tieda Technology (872541) closed at 17.17, down 6.17% with a trading volume of 62,100 shares and a transaction value of 109 million [1] - Other notable declines include Tieda Rail (6888889) down 5.35%, Tianzhixin Material (688033) down 4.43%, and Jiaotong Iron and Steel (920027) down 4.18% [1] Capital Flow - The rail transit equipment sector saw a net outflow of 606 million from institutional investors, while retail investors contributed a net inflow of 468 million [1] - The table of capital flow indicates that major stocks like Changqing Technology (001324) and Times New Materials (600458) experienced mixed capital inflows and outflows from different investor types [2]

Group 1 - The high-pressure oxygen chamber concept increased by 1.76%, ranking 7th among concept sectors, with 7 stocks rising, including Innovation Medical which hit the daily limit, and others like Beiyikang and Weiao Shares rising by 7.40%, 2.86%, and 0.74% respectively [1][2] - The concept sector saw a net inflow of 262 million yuan, with Innovation Medical receiving the highest net inflow of 472 million yuan, followed by Weiao Shares and Yingkang Life with net inflows of 3.37 million yuan and 769,200 yuan respectively [2][3] - The main capital inflow ratios for Innovation Medical, Weiao Shares, and Yingkang Life were 28.82%, 4.53%, and 0.85% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical with a daily increase of 10.03% and a turnover rate of 25.23%, while other stocks like Weiao Shares and Yingkang Life had increases of 2.86% and 0.68% respectively [3] - Conversely, stocks such as Tiedian Heavy Industry, Samsung Medical, and Jinling Pharmaceutical experienced declines of 1.50%, 0.70%, and 0.41% respectively, indicating a mixed performance within the sector [1][4]

Core Viewpoint - Weiao Co., Ltd. is developing a pressurized oxygen chamber technology aimed at improving human adaptability in high-altitude environments, which can alleviate symptoms of altitude sickness [1] Company Summary - Weiao Co., Ltd. has indicated that its oxygen chamber technology operates by simulating lower altitude conditions through pressurization, thereby increasing the oxygen partial pressure within the chamber [1] - The technology is particularly suitable for use in high-altitude regions, enhancing the body's ability to adapt to such environments [1] Industry Summary - The pressurized oxygen therapy market is likely to see growth due to increasing awareness of altitude sickness and the need for effective solutions in high-altitude areas [1] - The application of this technology could benefit various sectors, including tourism, sports, and healthcare, where high-altitude exposure is common [1]